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Diabetes is a major public health issue that has attained alarming levels worldwide. 
Pancreatic aggregates of human islet amyloid polypeptide (IAPP) represent a major 
histopathological hallmark of type 2 diabetes. IAPP is expressed in β-cells as pre-pro-IAPP 
(ppIAPP) that is first processed to pro-IAPP (pIAPP) and finally to its mature form (matIAPP), 
being released upon glucose stimulation together with insulin. Impairment and overload 
of the IAPP processing machinery seem to be associated with the accumulation of 
immature IAPP species and the formation of toxic intracellular oligomers, which have been 
associated with β-cell dyshomeostasis and apoptosis. Nevertheless, the pathological 
importance of these immature IAPP forms for the assembly and cytotoxicity of these 
oligomers is not completely understood. Here, we  describe the generation and 
characterization of unprecedented Saccharomyces cerevisiae models recapitulating IAPP 
intracellular oligomerization. Expression of green fluorescent protein (GFP) fusions of 
human ppIAPP, pIAPP, and matIAPP proved to be toxic in yeast cells at different extents, 
with ppIAPP exerting the most deleterious effect on yeast growth and cell viability. Although 
expression of all IAPP constructs induced the formation of intracellular aggregates in yeast 
cells, our data point out the accumulation of insoluble oligomeric species enriched in 
immature ppIAPP as the trigger of the high toxicity mediated by this construct in cells 
expressing ppIAPP-GFP. In addition, MS/MS analysis indicated that oligomeric species 
found in the ppIAPP-GFP lysates contain the N-terminal sequence of the propeptide fused 
to GFP. These models represent powerful tools for future research focused on the relevance 
of immature forms in IAPP-induced toxicity. Furthermore, they are extremely useful in 
high-throughput screenings for genetic and chemical modulators of IAPP aggregation.
Keywords: islet amyloid polypeptide, islet amyloid polypeptide-induced toxicity, oligomerization, protein aggregation, 
immature islet amyloid polypeptide, yeast model
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INTRODUCTION
Diabetes represents a major social and economic burden. The 
International Diabetes Federation estimated that, globally, 463 
million people were living with diabetes in 2019, and this 
number is predicted to attain 700 million by 2045 (International 
Diabetes Federation, 2019).
Type 2 diabetes mellitus (T2DM) is a multi-factorial disease 
with multiple contributing factors for its onset. The main features 
of the pathology are high glycemia due to inadequate insulin 
secretion/action and/or β-cell deficiency (Kahn et  al., 2014).
About 90% of T2DM individuals exhibit deposits of islet 
amyloid polypeptide (IAPP), also referred as amylin, in pancreatic 
islets (Westermark and Grimelius, 1973). IAPP is a hormone 
co-expressed, -processed, and -secreted with insulin by pancreatic 
β-cells upon glucose stimulation. Its physiological effects are 
mainly related to regulating gastric emptying, controlling adiposity 
and satiation and acting synergistically with insulin in stabilizing 
post-prandial blood sugar levels (Lutz, 2010; Akter et  al., 2016; 
Zhang et al., 2016). IAPP is synthesized as a 89-residue pre-pro-
IAPP (ppIAPP) from which the signal peptide (SP) is cleaved 
in the endoplasmatic reticulum (ER) to form pro-IAPP (pIAPP). 
This prohormone is then processed in the late Golgi complex 
by cleaving two flanking peptides by protein convertases (PCs) 
1/3 and 2, giving rise to mature IAPP (matIAPP; Westermark 
et  al., 2011). IAPP is stored in secretory granules of β-cells 
together with insulin, in a tightly controlled ratio, to ensure 
its solubility (Kahn et  al., 1993; Zhang et  al., 2016).
As a consequence of their simultaneous production, the boost 
in insulin production following hyperglycemia, observed under 
pathological conditions, is accompanied by hyperamylinemia, 
which is per se a trigger of IAPP oligomerization (Westermark 
et al., 2011). In addition, some evidences indicate that the overload 
of the processing machinery prompts the secretion and 
accumulation of immature IAPP forms (Marzban et  al., 2006; 
Paulsson et al., 2006; Chen et al., 2018). In fact, these intermediate 
species are claimed as more amyloidogenic than matIAPP (Paulsson 
and Westermark, 2005), they were found in cells models lacking 
PC (Marzban et  al., 2006) and in intracellular amyloid deposits 
of transgenic animals and human diabetic individuals (Paulsson 
et  al., 2006). Furthermore, the ratio of circulating pIAPP/IAPP 
was found to be altered in individuals with T2DM and impaired 
glucose tolerance (Zheng et al., 2010). Despite this, the pathological 
relevance of these immature IAPP forms for the assembly of 
cytotoxic oligomers remains to be  elucidated.
As IAPP species accumulate, oligomers start to form inside 
of the pancreatic β-cells. These oligomers have several known 
toxic effects, namely, inhibiting cell proliferation, deteriorating 
β-cells function (Shigihara et  al., 2014), increasing ER stress 
(Huang et al., 2007), and provoking defects in autophagy (Rivera 
et  al., 2014), among others. When the accumulation of these 
oligomeric species surpasses a certain threshold and cell defense 
mechanisms are no longer able to resolve them, there is the 
formation of larger amyloid fibrils, which lately culminates with 
the buildup of amyloid deposits that are hallmarks of the disease.
Several Saccharomyces cerevisiae models have been previously 
reported as powerful tools to study protein aggregation phenomena 
in other pathological contexts, namely, neurodegenerative diseases 
(Outeiro and Lindquist, 2003; Willingham et al., 2003; D’Angelo 
et  al., 2013; Oliveira et  al., 2017). In this study, we  describe 
novel yeast models expressing ppIAPP, pIAPP, and matIAPP 
fused to green fluorescent protein (GFP), which recapitulates 
intracellular aggregation, leading to marked toxicity and growth 
impairment, particularly in ppIAPP-GFP expressing cells. 
We show that increased cytotoxicity of ppIAPP-GFP is associated 
with the intracellular accumulation of insoluble oligomeric species 
enriched in immature ppIAPP. Furthermore, we  confirmed that 
oligomeric species found in the ppIAPP-GFP lysates contain 




BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (obtained from 
EUROSCARF) was the yeast strain used in this study. The 
plasmids used are listed in Supplementary Table S1. To 
construct p426-matIAPP-GFP, p426-Gal-aSyn-GFP (Outeiro 
and Lindquist, 2003) was digested with SpeI/HindIII to remove 
aSyn. The complementary DNA (cDNA) sequence of matIAPP 
was amplified by PCR and cloned into this vector using the 
In-Fusion Cloning kit (TAKARA Clontech). The same strategy 
was used to generate the remaining constructs upon replacement 
of the matIAPP sequence by the cDNA sequences corresponding 
to ppIAPP SP, ppIAPP, and pIAPP. Yeast transformation 
procedures were carried out as indicated using lithium acetate 
standard method (Gietz and Schiestl, 1991).
Growth Conditions
Synthetic dropout (SD)-glucose medium [0.67% (w/v) yeast 
nitrogen base (YNB) without amino acids (Difco, United States), 
0.77 g/L single amino acid dropout CSM-URA (MP Biomedicals, 
United  States), and 2% (w/v) glucose (Sigma-Aldrich, 
United  States)] was used for growth of cells transformed with 
p426-derived plasmids. A pre-inoculum was prepared in 
SD-raffinose medium [0.67% (w/v) YNB, 0.77  g/L CSM-URA, 
1% (w/v) raffinose (Sigma-Aldrich, United States)], and cultures 
were incubated overnight at 30°C under orbital shaking. Cultures 
were diluted in fresh medium and, unless stated otherwise, 
they were incubated under the same conditions until the optical 
density at 600  nm (OD600) reached 0.5  ±  0.05 (log growth 
phase). The following equation was used to synchronize the 
cultures: ODi  ×  Vi  =  ODf/[2(t/gt)]  ×  Vf, where ODi is the 
initial optical density of the culture, Vi is the initial volume 
of culture, ODf is the final optical density of the culture, t 
is the time (usually 16  h), gt is the generation time of the 
strain, and Vf is the final volume of culture. Readings were 
performed in 96-well plates using a Biotek Power Wave XS 
plate spectrophotometer. Cell cultures were diluted as indicated 
for each assay. In all experiments, repression or induction of 
constructs was carried out in SD-glucose medium and 
SD-galactose [0.67% (w/v) YNB, 0.77  g/L CSM-URA, 2% (w/v) 
galactose (Sigma®, Germany)], respectively.
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Flow Cytometry
Cell cultures were diluted to OD600 0.1  ±  0.01  in SD-galactose 
and incubated at 30°C for the indicated time points under 
orbital agitation. Cells were incubated with propidium iodide 
(PI) at a final concentration of 5  μg/ml for 30  min at 30°C 
under orbital agitation and protected from light. Flow cytometry 
was performed using a CyFlow Cube 6 (Sysmex Partec GmbH, 
Goerlitz, Germany), equipped with a blue solid-state laser 
(488 nm), green fluorescence channel (530/30 nm), and orange 
red fluorescence channel (610/20  nm). Data analysis was 
performed using FlowJo software. A minimum of 1,00,000 
events were collected for each experiment. Cell doublets exclusion 
was performed based on Forward-A and -W scatter parameters. 
Results were expressed as the percentage of PI+ and GFP+ 
positive cells as compared to the control.
Growth Assays
For the growth curves, cultures were diluted to OD600 
0.05  ±  0.005  in SD-glucose and SD-galactose and incubated 
at 30°C with shaking for 24  h. Growth was monitored hourly 
by measuring OD600 using a Biotek Power Wave XS Microplate 
Spectrophotometer (Biotek®, Winooski, United States). A model-
free spline (nonparametric) and a model fitting (parametric) 
approaches were used to calculate the growth parameters in 
the R software. The package grofit (Kahm et  al., 2010) was 
used to adjust a model-free spline, and the parameters, maximum 
cell growth (μm) and length of the lag phase (lag time), were 
estimated from the spline fit. The same package was also used 
to adjust to a model-based curve, and the parameters were 
estimated from the best fit model. The 95% confidence intervals 
(95% CIs) were calculated via bootstrapping for both model-
free spline and model-based fits. The results of the analysis 
are represented by the best model curve with 95% CIs for 
each strain compared to the control strain (not expressing IAPP).
Phenotypic Assays
For the phenotypic growth assays, cells were grown in 
SD-raffinose medium at OD600  =  0.4  ±  0.02, and the OD600 
was adjusted to 0.1  ±  0.01. Serial dilutions were performed 
with a ratio of 1:3, and 5  μl of each dilution was spotted 
onto solid SD-glucose and SD-galactose media. Growth was 
recorded after 48  h incubation at 30°C. Images were acquired 
using Chemidoc™ XRS and ImageLab® software.
Protein Extraction and Immunoblotting
Cell cultures were diluted to OD600 = 0.1 ± 0.01  in SD-galactose 
and incubated at 30°C for the indicated time points under 
orbital agitation. Cells were collected by centrifugation for 4 min 
at 2,500  g, the pellets were resuspended in Tris-buffered saline 
solution [TBS; Tris 2.4 g/L (Carl Roth GmbH, Germany), 8 
g/L NaCl (PanReac Applichem, Germany), pH 7.6] supplemented 
with protease and phosphatase inhibitors, cells were disrupted 
with glass beads (3 cycles of 30  s in the vortex and 5  min on 
ice), and cells debris were removed by centrifugation at 700  g 
for 3  min. Total protein was quantified using the MicroBCA 
kit (Thermo Fisher Scientific, United  States) according the 
manufactures’ instructions. Samples were incubated at 95°C for 
10 min before sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE). Ten micrograms of total proteins 
was loaded and resolved in Mini-Protean TGX Gels (Bio-Rad, 
United States). Gels were transferred to PVDF membranes using 
the Trans-Blot® SD semi-dry transfer system (Bio-Rad, 
United  States). Membranes were activated with methanol and 
blocked for 1  h at room temperature with 5% (w/v) bovine 
serum albumin (BSA, Sigma-Aldrich, United  States) dissolved 
in TBS-T [Tris 2.4  g/L (Carl Roth GmbH, Germany), 8  g/L 
NaCl (PanReac Applichem, Germany), and 0.1% (v/v) Tween 
20 (Sigma-Aldrich, United States)]. The primary antibodies against 
GFP (Neuromabs, California, United States), IAPP (Sigma-Aldrich, 
United States), and Pgk1 (Invitrogen, United States) were probed 
overnight at 4°C as indicated in Supplementary Table S2. The 
membranes were then washed 6 × 5 min in TBS-T and incubated 
with the appropriated secondary antibody for 1  h at room 
temperature. The membranes were washed 3 × 10 min in TBS-T 
and incubated with ECL™ Prime Western Blotting System (GE 
Healthcare, United States). Images were acquired using Chemidoc™ 
XRS and analyzed using ImageLab® software.
Fluorescence Microscopy
Cell cultures were diluted to OD600 = 0.1 ± 0.01 in SD-galactose, 
incubated at 30°C for 12 h under orbital agitation, and centrifuged 
at 3,000  g for 3  min. Slides were prepared using 4  μl of cell 
suspension, and mixed with 4  μl of low melting point agarose 
for samples to be  analyzed by confocal microscopy. GFP 
fluorescence was visualized using a Carl Zeiss LSM 710 (for 
confocal microscopy) or Leica Z2 (for fluorescence microscopy). 
Images were analyzed using Fiji-ImageJ1.51j8, United  States. 
The number of GFP positive (GFP+) cells and cells with 
aggregates and determination of aggregates area were evaluated 
by monitoring at least 800 cells for each condition.
Triton Soluble and Insoluble Fractions
Triton soluble and insoluble fractions were separated as described 
before (Tenreiro et  al., 2014). Briefly, 200  μg of total protein 
was incubated with 1% Triton X-100 for 30  min on ice. The 
protein was centrifuged at 15,000  g for 60  min at 4°C. The 
supernatant was considered the soluble protein fraction and 
collected. The pellet was resuspended in 40  μl of 2% sodium 
dodecyl sulphate (SDS) Tris-HCl buffer pH 7.4 by pipetting 
and 10  s of sonication and considered the insoluble fraction. 
Equal volumes of soluble and insoluble fractions were loaded 
and resolved by SDS-PAGE as described above.
Solubility Computational Predictor
The sequence of ppIAPP-GFP, which is equivalent to the other 
constructs with the exception of the regions that are removed 
during processing, was inserted into the free CamSol Intrinsic 
software (Sormanni et  al., 2015, 2017) and the solubility score 
per residue, for the whole IAPP-GFP sequence, was calculated 
assuming a pH of 7. Scores higher than 1 indicate highly 
soluble regions, while scores smaller than −1 suggest poorly 
soluble ones.
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Filter-Trap Assays
Protein lysates were prepared and quantified as indicated above. 
Increasing concentrations (5, 10, and 50  μg) of total proteins 
were diluted in TBS 1% (v/v) SDS, loaded onto a 0.22  μm pore 
nitrocellulose membrane (GE Healthcare, United  States), and 
pre-equilibrated with TBS in a slot blot apparatus. The samples 
were allowed to pass through the membrane by vacuum, and 
the slots were washed twice with TBS 1% (v/v) SDS. The membranes 
were blocked 1  h at room temperature with 5% BSA dissolved 
in TBS-T and incubated overnight with anti-IAPP primary antibody 
at 4°C (Supplementary Table S2). The membranes were washed 
6  ×  5  min in TBS-T and incubated with ECL™ Prime Western 
Blotting System (GE Healthcare, United  States). Images were 
acquired using Chemidoc™ XRS and ImageLab® software.
Mass Spectrometry
Protein extracts were obtained as indicated, and 10  μg of total 
proteins was loaded and resolved in Mini-Protean TGX Gels 
(Bio-Rad, United  States) in duplicates. One gel was processed 
for immunoblotting as indicated, and the corresponding signals 
were excised from the duplicate gel previously stained with 
InstantBlue™ (Sigma-Aldrich, United  States).
Mass spectometry sample preparation and analysis was carried 
out at Clarify Analytical (Portugal). Excised gel fragments were 
first washed with ultrapure water (100 μl) and incubated twice 
in 50% acetonitrile (ACN) triethylammonium bicarbonate (TEAB) 
50  mM at room temperature, under 1,500  rpm, for 5  min. 
Following washing with 100% ACN (100 μl), gel fragments were 
subsequently incubated with DTT 25  mM (100  μl) at 56°C for 
20 min, and then with IAA 55 mM (100 μl) at room temperature 
in the dark for 20  min. After washing with ultrapure water 
(100  μl), gel fragments were incubated twice with 50% ACN 
TEAB 50  mM (170  μl) at room temperature, under 1,500  rpm, 
for 5  min. Following washing with 100% ACN, the digestion 
was initiated upon trypsin (20 μl of enzyme in 0.01% surfactant 
in TEAB 50  mM) addition. About 0.01% surfactant in TEAB 
50 mM (30 μl) was added, whereupon the mixture was incubated 
at 37°C for 3 h and then at 50°C for 1 h. Samples were centrifuged 
at maximum speed for 10 s, and the supernatant were subsequently 
transferred to new microcentrifuge tubes to which 50% ACN 
1% TFA (20  μl) was added. Extracts were combined with the 
digestion, and gel was discarded. Following centrifugation at 
maximum speed for 10  min, samples were concentrated and 
resuspended in 0.1% TFA (10 μl) for ZipTip™ cleanup/enrichment 
(according to standard protocol) before mass spectrometry (MS) 
analysis. Protein identification was performed by nanoLC-MS/
MS, composed by an Ultimate 3000 liquid chromatography system 
coupled to a Q-Exactive Hybrid Quadrupole-Orbitrap Mass 
Spectrometer (Thermo Scientific, Bremen, Germany). Samples 
were loaded onto a trapping cartridge (Acclaim PepMap C18 
100  Å, 5  mm  ×  300  μm i.d., 160454, Thermo Scientific) in a 
mobile phase of 2% ACN, and 0.1% formic acid (FA) at 10  μl/
min. After 3  min loading, the trap column was switched in-line 
to a 50 cm by 75 μm inner diameter EASY-Spray column (ES803, 
PepMap RSLC, C18, 2 μm, Thermo Scientific, Bremen, Germany) 
at 250  nL/min. Separation was generated by mixing A: 0.1% 
FA and B: 80% ACN, with the following gradient: 2  min 
(2.5–10% B), 50  min (10–35% B), 8  min (35–99% B), and 
10 min (hold 99% B). Subsequently, the column was equilibrated 
with 2.5% B for 17  min. Data acquisition was controlled by 
Xcalibur 4.0 and Tune 2.9 software (Thermo Scientific, Bremen, 
Germany). The mass spectrometer was operated in data-dependent 
(dd) positive acquisition mode alternating between a full scan 
(m/z 380-1580) and subsequent HCD MS/MS of the 10 most 
intense peaks from full scan (normalized collision energy of 
27%). ESI spray voltage was 1.9  kV. Global settings: use lock 
masses best (m/z 445.12003), lock mass injection Full MS, and 
chrom. peak width (FWHM) 15  s. Full scan settings: 70  k 
resolution (m/z 200), AGC target 3e6, maximum injection time 
120 ms. dd settings: minimum AGC target 8e3, intensity threshold 
7.3e4, charge exclusion: unassigned, 1, 8, >8, peptide match 
preferred, exclude isotopes on, dynamic exclusion 45  s. MS2 
settings: microscans 1, resolution 35  k (m/z 200), automatic 
gain control (AGC) target 2e5, maximum injection time 110 ms, 
isolation window 2.0  m/z, isolation offset 0.0  m/z, spectrum 
data type profile. The raw data were processed using Proteome 
Discoverer 2.4.0.305 software (Thermo Scientific) and searched 
against the UniProt database for the Homo sapiens Proteome 
2019_09 and S. cerevisiae Proteome 2019_11. The fasta file for 
GFP was also included. The Sequest HT and MaxQuant search 
engines were used to identify tryptic peptides. The ion mass 
tolerance was 10 ppm for precursor ions and 0.02 Da for fragment 
ions. Maximum allowed missing cleavage sites was set 2. Cysteine 
carbamidomethylation was defined as constant modification. 
Methionine oxidation, protein N-terminus acetylation, methionine 
loss, and methionine loss plus acetylation were defined as variable 
modifications. Peptide confidence was set to high. The processing 
node target decoy PSM validator was enabled with maximum 
delta (Cn  =  0.05) and decoy database search target FDR 1%. 
Protein label free quantitation was performed with the Minora 
feature detector node at the processing step. Precursor ions 
quantification was performed at the processing step, including 
unique and razor peptides. The precursor abundance was based 
on intensity.
Size Exclusion chromatography
Total protein lysates were obtained as indicated and centrifuged 
at 10,000  g for 10  min to remove insoluble particles. Three 
micrograms of total protein was diluted in 2  ml of TBS buffer 
and loaded on a Superose 6 10/300 GL column (GE Healthcare, 
Uppsala, Sweden) using an AKTA system (GE Healthcare, 
Uppsala, Sweden). The samples were eluted with 1 mM potassium 
phosphate, 155 mM sodium chloride, 2.9 mM sodium phosphate 
buffer, pH 7.4 at a flow rate of 0.5  ml/min, and the UV 
absorbance was monitored at 280 nm. To estimate the molecular 
weight of the protein samples, Gel Filtration HMW Calibration 
Kit (GE Healthcare, Uppsala, Sweden) plus Ribonuclease (PanReac 
AppliChem, Spain) were used. Fractions of 500 μl were collected, 
precipitated overnight at 4°C in TCA, washed three times in 
acetone, resuspended in a protein sample buffer [0.12  M Tris-
HCl, pH 6.8, 9% (v/v) β-Mercaptoethanol, 20% (v/v) glycerol, 
4% (w/v) SDS, and 0.05% (w/v) Bromophenol Blue], and resolved 
by SDS-PAGE using Mini-Protean TGX Gels (Bio-Rad, 
United  States). Immunoblottings were performed as indicated.
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Statistical Analysis
Statistical analysis was carried out using Graphpad Prism 6 
software. Data are mean  ±  SD of at least three independent 
biological replicates. Two-way ANOVA with the Dunnett’s 
multiple comparison test was performed to access differences 
between the conditions. The t-test was used to access differences 
between the SP-GFP and ppIAPP-GFP conditions in the flow 
cytometry analysis. Two-way ANOVA with the Tukey’s multiple 
comparison test was performed to access differences in aggregates 
size between the conditions.
RESULTS AND DISCUSSION
Expression of Immature IAPP Forms in 
Yeast Mediates Higher Toxicity Than 
Mature IAPP
Some evidences suggest that impairment of ppIAPP processing 
and the consequent accumulation of intermediate immature 
forms may contribute to the formation of toxic intracellular 
oligomers (Paulsson and Westermark, 2005; Marzban et  al., 
2006; Paulsson et al., 2006). To compare the intracellular effects 
of IAPP forms in yeast, we  generated the chimeric constructs 
p426-ppIAPP-GFP (ppIAPP-GFP), p426-pIAPP-GFP (pIAPP), 
and p426-matIAPP-GFP (matIAPP; Supplementary Table S1), 
in which the respective cDNAs were cloned in frame with 
GFP under the control of the GAL1-inducible promoter. The 
presence of GFP expressing cells was first confirmed by flow 
cytometry (Supplementary Figure S1). The considerable standard 
deviation observed is possibly associated with the expression 
of IAPP constructs being driven by a multicopy plasmid, which 
may generate some variability in IAPP levels among biological 
replicates. Membrane integrity was then determined using PI 
staining as a measure to infer cell viability. None of the 
constructs p426 (control), p426-GFP (GFP), and p426-SP-GFP 
(SP-GFP) affected cell viability up to 12 h induction of protein 
expression with galactose (Figure  1A). The ppIAPP-GFP 
construct mediated high levels of toxicity after 12 and 24  h 
of induction with galactose. The control construct SP-GFP 
was shown to be toxic at 24 h (Figure 1A). As at 12 h ppIAPP-
GFP-mediated cytotoxicity was shown to be significantly higher 
than SP-GFP, with minor differences in the number of GFP+ 
cells for all GFP-expressing strains (Figure 1B; Supplementary 
Figure S1), we  selected this time point for further analysis. 
Nevertheless, 20.1  ±  5.0% of the yeast cells expressing 
ppIAPP-GFP was PI+, compared to only 5.5 ± 0.8% or 5.6 ± 2.6% 
of cells expressing pIAPP-GFP or matIAPP-GFP, respectively 
(Figures  1A,B).
The effects of ppIAPP-GFP, pIAPP-GFP, and matIAPP-GFP 
expression on cellular growth were assessed by means of growth 
curve analysis (Figure  1C). Cultures of cells expressing the 
three IAPP forms exhibited a short lag phase (corresponding 
to about one generation time), compatible with the switch from 
raffinose to galactose as the sole carbon source in the medium 
(Supplementary Figure S2A, left panel). Growth remained 
similar during the first 5  h when the strains expressing 
ppIAPP-GFP started to grow slightly slower than the control cells. 
In agreement with the reduction of viability observed in the 
flow cytometry assays (Figure 1A) after 9 h galactose induction, 
the growth defects of cells expressing ppIAPP-GFP were evident, 
whereas for pIAPP-GFP-expressing cells this effect could only 
be slightly detected at 12 h. In contrast, cells expressing matIAPP 
exhibited no growth defects (Figure 1C). The growth differences 
among strains are driven by the reduced “maximum growth 
rate” of ppIAPP-GFP and pIAPP-strains as compared to the 
control (Supplementary Figure S2A, right panel).
The deleterious effects of ppIAPP-GFP expression and pIAPP 
at a lesser extent were further corroborated by phenotypic 
assays, which clearly showed a dramatic reduction as compared 
with the control strain (Figure  1D). Although pIAPP-GFP and 
matIAPP-GFP did not compromise cell viability significantly, 
as indicated before by the flow cytometry analysis (Figure 1A), 
these constructs interfere with cellular growth, more pronouncedly 
in pIAPP-GFP than in matIAPP-GFP. Altogether, these results 
demonstrate that expressions of the three IAPP forms (ppIAPP, 
pIAPP, and matIAPP) are toxic to yeast cells at different degrees. 
Noteworthy, the immature forms, particularly the full-length 
ppIAPP, are the most toxic.
Intracellular Aggregates Are Formed in 
Cells Expressing IAPP
To understand the mechanisms by which the expression of 
IAPP immature forms induced higher toxicity in yeast than 
matIAPP, we next carried out immunoblotting assays. As depicted 
in Figure  2A, the levels of ppIAPP-GFP, pIAPP-GFP, and 
matIAPP-GFP proteins were shown to be  different among 
strains, with no significant impact in the number of GFP+ 
cells, as revealed by the flow cytometry analysis (Supplementary 
Figure S1). Total protein lysates from cells expressing 
ppIAPP-GFP revealed the presence of a 38 kDa signal compatible 
with the molecular weight of the full-length ppIAPP-GFP fusion. 
Remarkably, two additional IAPP-specific signals of ~32 and 
~75  kDa were detected in this lysate (Figure  2A). In a similar 
manner, pIAPP-GFP-protein lysates disclosed the presence of 
a 36 kDa signal, matching the molecular weight of the pIAPP-GFP 
fusion and two extra signals of ~32 and ~70  kDa. At this 
point, we speculated that these signals may represent processing 
intermediates (~32  kDa signals) and dimers of ppIAPP-GFP 
and pIAPP-GFP (~70 and 75  kDa signals, respectively). Total 
protein lysates from cells expressing matIAPP-GFP revealed 
the presence of a single signal of ~31  kDa and well-matched 
with the molecular weight of the mature construct. Similar 
results were observed when the membranes were incubated 
with anti-GFP antibody (Supplementary Figure S3); however, 
an immunoreactive signal of ~60  kDa was detected in the 
lysates of cells expressing matIAPP-GFP. Also, a signal of 
~30  kDa, that was not detected by the anti-IAPP antibody, 
was revealed in the lysates of cells expressing ppIAPP-GFP 
and pIAPP-GFP. Considering that ppIAPP and pIAPP may 
be  processed by endogenous yeast convertases such as Kex2 
(Fuller et al., 1989a,b; Kjeldsen, 2000), this signal may correspond 
to GFP fused to the C-terminal flanking peptide located 
downstream of the PC1/3 cleavage site both in ppIAPP and 
pIAPP (Figure  3C).
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As the immunoblotting assays suggested the presence of 
oligomers in cells expressing ppIAPP-GFP, pIAPP-GFP, and 
possibly also matIAPP-GFP, we  then performed confocal 
microscopy to follow the subcellular dynamics of chimeric 
proteins. Cells expressing ppIAPP-GFP displayed a heterogenous 
distribution of well-defined intracellular aggregates in most 
of the fluorescent cells (Figure  2B). pIAPP-GFP and 
matIAPP-GFP cells presented a more diffuse fluorescence 
pattern throughout the cell and decorated with less sharply 
defined aggregates. These differences in fluorescence patterns, 
together with the impairment of cell viability and growth of 
ppIAPP-GFP strain (Figure  1), may explain the decreased 
number of GFP+ cells after 9  h induction of ppIAPP-GFP 
expression (Supplementary Figure S1).
Noteworthy, both in pIAPP-GFP and matIAPP-GFP, it is 
possible to detect aggregates in a non-fluorescent compartment, 
presumably the vacuole, indicating the accumulation of 
intravacuolar aggregates.
The subcellular dynamics of aggregates formed in the different 





FIGURE 1 | Expression of pre-pro-islet amyloid polypeptide-green fluorescent protein (ppIAPP-GFP) in yeast impairs cell viability and growth. (A) BY4741 cells 
expressing IAPP-GFP fusions and the respective controls were induced with galactose for the indicated time points, and the frequency of propidium iodide (PI) 
positive cells was assessed by flow cytometry. (B) IAPP-GFP vs. PI fluorescence clouds after 12 h galactose induction as determined by flow cytometry.  
(C) Parametric adjustment of growth curves, with confidence intervals (CIs), based on culture optical density at 600 nm (OD600) of yeast cells expressing IAPP-GFP 
fusions, compared to cells that are not expressing the human protein. (D) Phenotypic assays of the indicated strains. Cell suspensions were adjusted to the same 
OD600 serially diluted and spotted onto the surface of solid medium containing either glucose or galactose. Representative images are shown, and the values 
represent mean ± SD from at least three independent experiments. Statistical differences are denoted as **p < 0.01, and ***p < 0.001 vs. the control condition; 
#p < 0.05 vs. signal peptide-GFP (SP-GFP).
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three IAPP forms into different molecular pathways and may 
explain why the full-length ppIAPP-GFP triggers higher toxicity 
to yeast cells than the other forms.
We next used fluorescence microscopy to assess the frequency 
of cells displaying IAPP aggregates (Figure  2C; Supplementary 
Figure S4). For that, we  first counted the number of GFP+ cells, 
which were shown to be  statistically similar, in support of the 
results of the flow cytometry analysis (Supplementary Figure S1). 
From those, we determined the number of cells bearing aggregates 
and measured the area of those aggregates. The data confirmed 
the presence of aggregates in cells expressing all constructs. 
ppIAPP-GFP cells were the ones displaying the higher number 
of cells with aggregates as compared to pIAPP-GFP and 
matIAPP-GFP, which presented similar numbers of cells with 
aggregates. Furthermore, monitoring of aggregates area indicated 
that ppIAPP-GFP-expressing cells accumulated aggregates of smaller 
average area than the other strains (Figure  2D). Furthermore, 
the frequency analysis distribution of the size of the aggregates 
indicates that ppIAPP-GFP and pIAPP-GFP have a distribution 
centered on smaller aggregates, in contrast to matIAPP-GFP 
which presents a broader distribution, with a bigger percentage 
of aggregates of larger area (Supplementary Figure S5).
To verify if the fluorescent structures seen in the microscopy 




FIGURE 2 | IAPP-GFP fusions expressed in yeast are processed and lead to the formation of intracellular aggregates with different morphologies. (A) BY4741 cells 
expressing IAPP-GFP fusions and the control construct were induced with galactose for 12 h, and proteins were assessed by immunoblotting using anti-IAPP 
antibody. Pgk1 was used as loading control. (B) Confocal fluorescence imaging of ppIAPP-GFP, pro-IAPP (pIAPP)-GFP, and mature IAPP (matIAPP)-GFP cells 
induced with galactose for 12 h. Scale bars correspond to 5 μm. (C) Cells under the same conditions were analyzed by fluorescence microscopy, and the number 
of fluorescent cells as well as the number of cells containing aggregates was monitored. Full colors: GFP + cells; colored patterns: cells with aggregates.  
(D) Aggregate area was measured in cells containing aggregates. Representative images are shown, and the values represent mean ± SD from at least three 
independent experiments. Statistical differences are denoted as *p < 0.05 and ***p < 0.001.
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the cell lysates were separated in Triton soluble and insoluble 
fractions. All strains displayed insoluble IAPP aggregates 
(Figure  3A; Supplementary Figure S6). The quantification of 
the ratio insoluble/total proteins clearly showed that ppIAPP-GFP 
strain has a higher proportion of insoluble aggregates compared 
to the other strains (Figure  3B). Remarkably, the signal 
corresponding to immature forms of ppIAPP-GFP and 
pIAPP-GFP could only be  detected in the total extracts and, 
at a higher extent, in the insoluble fraction (Figure  3A; 
Supplementary Figure S6). This suggests that the aggregates 
formed by IAPP immature forms are more insoluble than the 





FIGURE 3 | Immature IAPP entities are restricted to Triton insoluble fractions and are differentially retained in filter-trap assays. (A) The protein extracts were 
separated according to their solubility and assessed by immunoblotting using anti-IAPP antibody. Pgk1 was used as loading control. (B) The ratio between the 
insoluble fraction and total protein was calculated for each strain. (C) Schematic representation of IAPP processing and solubility. The sequences of the signal 
peptide (SP; dark blue), the N-terminal and C-terminal flanking regions of the propeptide (medium blue), and the matIAPP (light blue) as well as the processing sites 
of the prohormone convertases PC2 and PC1/3 are shown. The intrinsic solubility of each amino acid of the full length ppIAPP was predicted computationally (lower 
panel). (D) Filter-trap assays of total protein lysates obtained from ppIAPP-GFP, pIAPP-GFP, and matIAPP-GFP cells induced with galactose for 12 h, and probed 
with anti-IAPP antibody. Protein concentration loaded in the membranes: 50, 10, and 5 μg (from left panel to right panel). Representative images are shown, and the 
values represent mean ± SD from at least three independent experiments. Statistical differences are denoted as *p < 0.05.
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by the computational predictor that applies the CamSol Intrinsic 
algorithm on the different fusion proteins, defining a solubility 
score for each one based on the contribution of each amino 
acid in the protein sequence (Supplementary Figure S7). The 
predictions indicate that ppIAPP-GFP is the most insoluble 
of the three forms, with pIAPP-GFP and matIAPP-GFP presenting 
a similar score. Furthermore, evaluating the intrinsic solubility 
of each amino acid of the full length ppIAPP individually 
(which also contains the pIAPP and IAPP), as detailed in 
Figure  3C, it was possible to assess the high contribution of 
the SP to ppIAPP insolubility.
To further corroborate these results, total protein extracts 
were subjected to filter-trap assays, an extensively used tool to 
assess the formation of intracellular aggregates (Juenemann et al., 
2015; Nasir et  al., 2015; Cox and Ecroyd, 2017). Surprisingly, 
lysates from pIAPP-GFP-expressing cells displayed a strong signal 
revealing the presence of high amounts of IAPP SDS-insoluble 
aggregates, as opposed to the lysates of cells expressing ppIAPP-GFP 
and matIAPP-GFP (Figure  3D). However, these results should 
be  interpreted with caution as the protein levels of IAPP-GFP 
fusions are extremely variable among strains (Figure  2A).
Identification of Peptides Present in the 
Putative Oligomeric and Processed IAPP 
Forms
In addition to the signals clearly corresponding to monomeric 
forms of ppIAPP-GFP and pIAPP-GFP, the respective lysates 
also revealed the presence of other IAPP-immunoreactive signals 
of high and low molecular weight (Figure  2A). To assess the 
identity of these protein species by nanoLC-MS/MS, the 
corresponding SDS-PAGE gel fragments were excised 
(Supplementary Figure S8), and the proteins were digested with 
trypsin and purified before loading of the peptide mixture on 
the trapping cartridge. Searching the raw data against the UniProt 
database for Homo sapiens, S. cerevisiae, and the fasta file for 
GFP led to the identification of hundreds of proteins, including 
unique tryptic peptides for IAPP (Table  1), particularly the 
peptide [R].NAVEVLKR.[E], corresponding to the C-terminal 
sequence of IAPP propeptide (Figure  3C), that was detected 
in the three samples. The internal IAPP peptide [R].
LANFLVHSSNNFGAILSSTNVGSNTYGKR.[N] was also identified 
in sample #3, corresponding to the low molecular weight bands 
in pIAPP-GFP lysates (Supplementary Figure S8). Analysis 
using the MaxQuant also identified the peptide [R].
LANFLVHSSNNFGAILSSTNVGSNTYGK.[R] in the same sample. 
As expected, tryptic peptides for GFP were also detected in all 
samples. These data confirm that the high molecular weight 
species observed in the ppIAPP-GFP lysates contains the 
C-terminal end of IAPP propeptide fused to GFP, as it is also 
immunoreactive for GFP (Supplementary Figure S3). In addition, 
they suggest that the low molecular weight species observed in 
the ppIAPP-GFP and pIAPP lysates may represent processing 
intermediates cleaved by endogenous yeast convertases.
IAPP Oligomeric Species of Different  
Sizes Accumulate in Cells Expressing 
ppIAPP-GFP
ppIAPP-GFP expressing cells exhibited more cells with aggregates, 
which seem to have a different nature of the ones accumulated 
in pIAPP-GFP and IAPP-GFP cells, and that cause a strong 
impairment of viability and growth. In an attempt to understand 
the toxic nature of ppIAPP-GFP, we  performed size exclusion 
chromatography, a widely established methodology for the 
biochemical characterization of protein species. After 
fractionation of lysates from ppIAPP-GFP, pIAPP-GFP, and 
matIAPP-GFP expressing cells, we  detected IAPP species in 
different fractions depending on the strain (Figure  4). 
ppIAPP-GFP and pIAPP-GFP proteins were mostly eluted 
between fractions 28 and 42, corresponding to low molecular 
weight species, presumably low-order oligomers and monomers. 
Stronger signals were detected in fractions 32–35 of pIAPP-GFP 
extracts, suggesting the accumulation of higher molecular weight 
species in this strain as compared to ppIAPP-GFP. In both 
strains, a small amount of even higher molecular weight species 
(>669  kDa) was also observed in fractions 17–20. Noteworthy, 
for the matIAPP-GFP strain, most of the protein signals were 
detected in fractions 14–20. In summary, according to the 
molecular weight of IAPP species detected, the strains can 
TABLE 1 | Identification of IAPP peptides by NanoLC-MS/MS.






0.012 2.06 9 1 [R].NAVEVLKR.[E]
#2 LMW 
ppIAPP-GFP









HMW, high molecular weight signal; LMW, low molecular weight signal. 
aRelative molecular mass.
bIsoelectric point.
cExpect value – probability of the observed match between the experimental data, and mass values calculated from a candidate peptide or protein sequence, occur due to random event.
dMascot score that is calculated by −10Log10(P), where P is the absolute probability that observed match is random event.
ePercentage of sequences hit for registered full sequence.
fNumber of peptide fragments matching the candidate protein.
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be  ranked as follows: IAPP-GFP  >  pIAPP-GFP  >  ppIAPP-GFP. 
These may comprise the aggregated species detected in previous 
assays (Figure  2).
Altogether, these results convincingly corroborate the idea 
that accumulation of insoluble oligomeric species of smaller 
sizes, enriched in immature ppIAPP, may explain the high 
toxicity triggered by this construct in cells expressing 
ppIAPP-GFP.
The toxic nature of IAPP aggregates has been described in 
several studies linking IAPP to T2DM. Aggregates of synthetic 
human IAPP are able to induce apoptosis of β-cells from adult 
pancreas of rats and humans (Lorenzo et  al., 1994), and 
inhibition of IAPP synthesis/aggregation can ameliorate β-cell 
death in culture human islets (Potter et  al., 2009). Aggregation 
of synthetic IAPP in vitro occurs in a concentration-dependent 
manner (Bailey et  al., 2011), suggesting that the levels of IAPP 
present in vivo might be a key contributing factor for aggregates 
formation. In fact, it has been reported that overexpression 
of human IAPP in cells can lead to intracellular IAPP aggregation 
and amyloid formation. Although logical, this process is not 
so simple, and heterogeneity between β-cells of transgenic 
models for the formation of detectable human IAPP aggregates 
was also reported and attributed to differences in chaperone 
ability, protein trafficking, and capacity to clear misfolded and 
aggregated proteins (Lin et  al., 2007).
The size, nature, and composition of these aggregated species 
have been a focus of research for a long time. Nonfibrillar 
IAPP toxic oligomers were detected in two transgenic human 
IAPP mouse models at the time of maximal loss of β-cell 
mass. These oligomeric species were found to be  confined to 
β-cells in the perinuclear region and in frequent small discrete 
deposits, therefore supporting their ability to act on intracellular 
molecular pathways (Lin et  al., 2007). Besides the size of 
aggregates, findings suggest that deficiencies in processing of 
immature IAPP forms could be  associated with an increase 
in amyloidogenicity and, consequently, in cytotoxicity. Expression 
of human pIAPP in GH3 cells lacking prohormone convertases 
lead to an accumulation of unprocessed and partially processed 
forms of pIAPP that markedly increased cell death (Marzban 
et  al., 2004). In INS-1 cells, however, expression of human 
pIAPP did not promote cytotoxicity unless pIAPP expression 
was high enough to cause an impairment in the processing 
pathway (Marzban et  al., 2006).
In our study, even though all forms of IAPP form aggregates 
when overexpressed in yeast, those of immature forms cause 
a more marked toxicity, particularly ppIAPP-GFP. These data 
bring forward the importance of IAPP processing on the 
progress of IAPP fibrillization and aggregation, making clear 
the need for further research.
Furthermore, our data suggest that pIAPP-GFP expression 
leads to increased formation of aggregates bigger than 0.22 μm 
but that these are less toxic than the aggregates formed in 
cells expressing ppIAPP-GFP. This comes in line with findings 
indicating that smaller oligomers are the drivers of toxicity 
FIGURE 4 | Yeast expressing ppIAPP-GFP accumulates high levels of intracellular oligomers with low molecular weight as compared to pIAPP-GFP and matIAP-
GFP strains. The aggregated species formed by the different IAPP-GFP fusion were resolved using size exclusion-chromatography (SEC) after 12 h of cell induction 
of galactose. Fractions were collected and separated on SDS-PAGE followed by immunoblot analyses. A representative result is shown from at least three 
independent experiments.
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and not mature fibrils (Janson et  al., 1999; Kayed et  al., 2007; 
Haataja et  al., 2008; Gurlo et  al., 2010; Abedini et  al., 2016). 
Finally, analysis of the solubility of the formed aggregates, as 
well as in silico predictions, indicates that the inclusions have 
different physicochemical properties. This suggests that aggregates 
formed by mature or immature forms, or putatively a mixture 
of species, can contribute differently for the oligomerization 
process and its consequent toxicity.
Recently, a yeast model expressing a genetically-encoded 
matIAPP oligomer fused to the SP of yeast Kar2, an ER 
chaperone required for secretory polypeptide translocation, was 
described (Kayatekin et  al., 2018). In this model, core IAPP-
driven pathological mechanisms were uncovered, and powerful 
insights into the IAPP cytotoxicity were disclosed. As it relies 
on the expression of a genetically encoded hexamer of matIAPP 
fused to a yeast SP, important aspects concerning ppIAPP 
processing, and the contribution of immature IAPP forms to 
the oligomerization process and cytotoxicity cannot be addressed. 
In that view, this study describes unprecedented yeasts models 
expressing the full-length human ppIAPP, the intermediated 
form pIAPP, and matIAPP fused to GFP, which represent a 
novel and powerful tool to investigate the molecular mechanisms 
underlying IAPP proteotoxicity.
CONCLUSION
Diabetes represents a major social and economic burden and 
alarming projections for diabetes incidence emphasize the need 
of novel therapeutic/detection strategies to minimize disturbing 
future scenarios. The first high-impact study describing IAPP 
as an important factor for T2DM was published in 1994. Since 
then, and although considerable progress has been made, islet 
amyloid and the precise pathways by which IAPP aggregation 
causes β-cell death remain somewhat of an enigma in the 
T2DM field. Opposing to previous ideas, IAPP intracellular 
oligomers are an early molecular event preceding amyloid 
deposition and irreversible loss of β-cell functionality. An 
additional question of some debate is whether IAPP aggregation 
initiates intracellular or extracellularly. The amyloidogenic 
properties of human IAPP allied with its overproduction and 
secretion from β-cells are likely a relevant contributor, but 
they do not seem to be  sufficient for islet amyloid formation. 
In this perspective, defective trafficking and processing of 
immature forms of IAPP associated with β-cell dysfunction 
have been proposed to be a critical trigger for IAPP aggregation. 
Despite that, the pathological relevance of these unprocessed 
IAPP species for the assembly of cytotoxic oligomers remains 
obscure, whereby further studies should be  addressed.
The relevance of IAPP proteotoxicity for diabetes 
pathophysiology and the potential reversibility of oligomers 
formation make IAPP an attractive target for the design of 
novel prophylactic, therapeutic, and diagnostic strategies. Our 
study gives an important contribution to the recent views that 
point out immature forms of IAPP as the most deleterious 
for cell survival, highlighting the toxic role of ppIAPP hitherto 
overlooked. Indeed, the unprecedented models here described 
represent powerful tools to further investigate the impact of 
immature forms on IAPP aggregation and proteotoxicity. 
Unveiling the IAPP aggregation pathway and identifying the 
toxic species of IAPP is of great importance to the development 
of new therapies capable of interfering with IAPP toxic 
oligomerization and consequent amyloid formation. In that 
regard, the versatility of the models here presented can also 
be  exploited in high-throughput screenings for genetic and 
chemical modulators of IAPP aggregation.
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